SCHEMBL5773366

SCHEMBL5773366

CCOP(=O)(Cc1ccc(NC(=O)CCCc2cnoc2-c2ccccc2)cc1)OCC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.43
EPHX2 P34913 1/20 0.43
MAPT P10636 6/20 0.41
LMNA P02545 3/20 0.41
ALDH1A1 P00352 2/20 0.41
MAPK1 P28482 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ENPP2 Q13822 1/20 0.41
DGAT2 Q96PD7 1/20 0.41
THRB P10828 1/20 0.39
HDAC3 O15379 3/20 0.39
HDAC1 Q13547 3/20 0.39
HDAC2 Q92769 3/20 0.39
HDAC6 Q9UBN7 3/20 0.39
HDAC4 P56524 2/20 0.39
HDAC7 Q8WUI4 2/20 0.39
HDAC10 Q969S8 2/20 0.39
HDAC11 Q96DB2 2/20 0.39
HDAC8 Q9BY41 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5771726 0.94 LTA4H (0.46) LTA4HEPHX2MAPTLMNAALDH1A1
SCHEMBL5773844 0.91 HDAC3 (0.40) MAPTLMNAALDH1A1MAPK1MEN1
SCHEMBL5776409 0.89 MEN1 (0.42) LTA4HEPHX2MAPTLMNAALDH1A1
SCHEMBL5772612 0.87 LTA4H (0.46) LTA4HEPHX2MAPTLMNAALDH1A1
SCHEMBL5774078 0.87 LTA4H (0.53) LTA4HEPHX2MAPTLMNAALDH1A1
SCHEMBL5771359 0.85 MEN1 (0.40) LTA4HEPHX2MAPTLMNAALDH1A1
SCHEMBL5777451 0.85 MEN1 (0.41) LTA4HEPHX2MAPTLMNAALDH1A1
SCHEMBL5777014 0.85 MEN1 (0.46) LTA4HEPHX2MAPTLMNAMAPK1
SCHEMBL5770775 0.85 MAPT (0.41) LTA4HEPHX2MAPTLMNAALDH1A1
SCHEMBL5773001 0.84 LTA4H (0.38) LTA4HEPHX2MAPTLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR LTA4H 3298/4885EPHX2 1846/4885MAPT 4701/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 LTA4H 3891/4885EPHX2 2389/4885MAPT 4763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.